Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: Clinical Study on the Efficacy and Safety of BAT5906 Injection [Phase 2]

View source ↗

Summary

Phase 2 trial update on BAT5906 injection assessing efficacy and safety in wet age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BAT5906 (BAT5906)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Wet Age-related Macular Degeneration | Phase 2 | Status: COMPLETED